CPT1A and diabetic kidney disease: In a recent experiment, Carnitine palmitoyltransferase-1A (CPT1A), a key rate-limiting enzyme in fatty acid oxidation (FAO), has been shown to protect podocytes from lipotoxicity and apoptosis in vitro, and demonstrates promising therapeutic benefits in vivo for DKD [136].